Estonia - estoniană - Ravimiamet

laboratoires thea - timolool+latanoprost - silmatilgad, lahus - 5mg+50mcg 1ml 6ml 1tk; 5mg+50mcg 1ml 2.5ml 1tk

Uniunea Europeană - estoniană - EMA (European Medicines Agency)

leo pharma a/s - tralokinumab - dermatiit, atoopiline - muud dermatoloogilised preparaadid - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.

Uniunea Europeană - estoniană - EMA (European Medicines Agency)

koanaa healthcare gmbh - imatinib mesilate - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma; gastrointestinal stromal tumors - antineoplastilised ained - imatinib koanaa is indicated for the treatment ofadult and paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment. adult and paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis. adult and paediatric patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph+ all as monotherapy. adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements. adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfrα rearrangement. the effect of imatinib on the outcome of bone marrow transplantation has not been determined. imatinib koanaa is indicated forthe treatment of adult patients with kit (cd 117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). the adjuvant treatment of adult patients who are at significant risk of relapse following resection of kit (cd117)-positive gist. patsientidel, kellel on madal või väga madal risk kordumise ei tohiks saada abiaine ravi. the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic gist and dfsp and on recurrence-free survival in adjuvant gist. the experience with imatinib in patients with mds/mpd associated with pdgfr gene re-arrangements is very limited (see section 5. välja arvatud äsja diagnoositud kroonilise faasi cml, ei ole kontrollitud uuringud, mis näitab kliiniline kasu või suurenenud ellujäämise eest need haigused.

Estonia - estoniană - Ravimiamet

lex ano uab - valatsikloviir - õhukese polümeerikattega tablett - 500mg 10tk

Estonia - estoniană - Ravimiamet

sia elvim - latanoprost - silmatilgad, lahus - 50mcg 1ml 2.5ml 1tk

Estonia - estoniană - Ravimiamet

lex ano uab - valatsikloviir - õhukese polümeerikattega tablett - 500mg 10tk

Estonia - estoniană - Ravimiamet

accord healthcare b.v. - gabapentiin - kõvakapsel - 100mg 500tk; 100mg 200tk; 100mg 50tk; 100mg 20tk; 100mg 30tk; 100mg 84tk; 100mg 1000tk; 100mg 98tk; 100mg 60tk

Estonia - estoniană - Ravimiamet

woerwag pharma gmbh & co. kg - gabapentiin - kõvakapsel - 300mg 50tk; 300mg 500tk; 300mg 250tk; 300mg 20tk; 300mg 200tk; 300mg 1000tk; 300mg 30tk; 300mg 10tk

Estonia - estoniană - Ravimiamet

accord healthcare b.v. - gabapentiin - kõvakapsel - 400mg 1000tk; 400mg 100tk; 400mg 50tk; 400mg 98tk; 400mg 500tk

Estonia - estoniană - Ravimiamet

ranbaxy (u.k.) limited - timolool+latanoprost - silmatilgad, lahus - 5mg+50mcg 1ml 2.5ml 3tk; 5mg+50mcg 1ml 2.5ml 6tk